Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/L502601/1)
AstraZeneca UK (BB/L502601/1)
Text and Data Mining valid from 2018-07-23
Received: 14 June 2018
Accepted: 6 July 2018
First Online: 23 July 2018
Ethics approval and consent to participate
: All housing and experimental procedures were carried out in compliance with the local ethical review panel of King’s College London under a UK Home Office project license held in accordance with the Animals (Scientific Procedures) Act 1986 and the European Directive 2010/63/EU. Regarding sigmoid biopsies sampling, the study protocol was approved by the local Committee on Ethics and Human Research ( Comité de Protection des Personnes Ouest VI ), and registered on ClinicalTrials.gov (EnteroLark and ColoBioParker, identifier NCT01618383 and NCT01353183, respectively). Written informed consent was obtained from each patient and from each normal volunteer.
: Not applicable.
: Michael S. Perkinton is an employee of MedImmune.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.